Fate Therapeutics Inc. Email Format
Biotechnology ResearchCalifornia, United States201-500 Employees
Fate Therapeutics Inc is a clinical-stage biotechnology company focused on developing iPSC-derived cellular immunotherapies for cancer and autoimmune diseases. It leverages a proprietary iPSC platform to generate multiplexed-engineered master iPSC lines and to manufacture off-the-shelf iPSC-derived cell products for clinical development. The company’s pipeline includes iPSC-derived T-cell and natural killer (NK) cell product candidates designed with synthetic controls of cell function to enable multiple therapeutic mechanisms. Fate Therapeutics is headquartered in San Diego, California, and employs 201-500 people. The firm has positioned itself as a leader in the field of off-the-shelf iPSC-derived cell therapies, with activities spanning preclinical and clinical development.